Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo

2746.967 - 2771.019 Dr. Bogdana Schmidt

And you're right. We may see different data in longer-term follow-up. And once the noise, kind of the numbers of the patients that drop off, we might get a clearer signal with that. These are all still in the abstract phase. So we might learn more in that. But I still think it's exciting and promising. And so to get to exciting and promising, we've talked about periop immunotherapy.